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Abstract
Introduction Traumatic brain injury and generalized convulsive
status epilepticus (GCSE) are conditions that require
aggressive management. Barbiturates are used to lower
intracranial pressure or to stop epileptiform activity, with the aim
being to improve neurological outcome. Dosing of barbiturates
is usually guided by the extent of induced burst-suppression
pattern on the electroencephalogram (EEG). Dosing beyond the
point of burst suppression may increase the risk for
complications without offering further therapeutic benefit. For
this reason, careful monitoring of EEG parameters is mandatory.
A prospective study was conducted to evaluate the usefulness
of the bispectral index suppression ratio for monitoring
barbiturate coma.
Methods A prospective observational pilot study was
performed at a paediatric (surgical) intensive care unit, including
all children with barbiturate-induced coma after traumatic brain
injury or GCSE. The BIS™ (Bispectral™ index) monitor
expresses a suppression ratio, which represents the percentage
of epochs per minute in which the EEG was suppressed.
Suppression ratios from the BIS monitor were compared with
suppression ratios of full-channel EEG as assessed by
quantitative visual analysis.
Results Five patients with GCSE and three patients after
traumatic brain injury (median age 11.6 years, range 4 months
to 15 years) were included. In four patients the correlation
between the suppression ratios of the BIS and EEG could be
determined; the average correlation was 0.68. In two patients,
suppression ratios were either high or low, with no intermediate
values. This precluded determination of correlation values, as
did the isoelectric EEG in a further two patients. In the latter
patients, the mean ± standard error BIS suppression ratio was
95 ± 1.6.
Conclusion Correlations between suppression ratios of the BIS
and EEG were found to be only moderate. In particular,
asymmetrical EEGs and EEGs with short bursts (less than 1
second) may result in aberrant BIS suppression ratios. The BIS
monitor potentially aids monitoring of barbiturate-induced coma
because it provides continuous data on EEG suppression
between full EEG registrations, but it should be used with
caution.
Introduction
Traumatic brain injury (TBI) and generalized convulsive status
epilepticus (GCSE) are conditions that require aggressive
management. Barbiturates are used to stop epileptiform activ-
ity, with the aim being to improve neurological outcome. Other
effects of high barbiturate levels are reduced cerebral metab-
olism and blood flow, which also are favourable in the treat-
ment of severe epilepsy [1]. Barbiturate therapy also has
serious adverse effects, however, in particular cardiovascular
depression and hypotension [2,3]. Dosing of barbiturates is
guided by the extent of induced burst-suppression pattern on
the electroencephalogram (EEG) [4]. Dosing beyond the point
of burst suppression may increase the risk for complications
without offering further therapeutic benefit [3]. For this reason,
careful monitoring of EEG parameters is mandatory.
Several methods of monitoring barbiturate coma are available:
interval or continuous EEG monitoring, and regular testing ofPage 1 of 7
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orkers [5] demonstrated that continuous EEG monitoring was
the best modality because it showed the presence of burst
suppression on a moment-to-moment basis. They also found
poor correlations between serum and cerebrospinal fluid bar-
biturate levels at any given time, suggesting that barbiturate
levels are difficult to interpret because of inter-individual differ-
ences in distribution and metabolism [5]. Another possibility is
that barbiturate levels are difficult to interpret because of
changes in receptor sensitivity [6].
When EEG is used to determine the optimal depth of a barbit-
urate coma, the goal is to induce a burst suppression pattern
[5]. A practical drawback of the standard EEG recording
method is that recording and interpretation requires qualified
EEG technicians and a clinical neurophysiologist. In addition,
most centres do not have the facilities to monitor EEGs and
have the EEG interpreted by qualified clinical neurophysiolo-
gists continuously for hours to days or even weeks [7-9].
In summary, clinical evaluation of a pentobarbital coma is diffi-
cult; barbiturate blood levels may not be reliable and continu-
ous full-channel EEG monitoring is not feasible in many
centres, as in ours. Hence, monitoring of a barbiturate coma
using the Bispectral™ index (BIS™; Aspect Medical Systems,
Newton, MA, USA) monitor is an interesting possibility. This
monitor provides a suppression ratio (SR-BIS) and raw EEG
traces, which are continuously displayed, thus enabling moni-
toring of cerebral function. The BIS monitor is relatively easy to
use, and nurses and physicians can be taught how to interpret
recordings.
We hypothesized that if the optimal SR-BIS values and EEG
trace displayed on the BIS monitor are similar to the full chan-
nel EEG and remain stable, then the BIS monitor could be
used to monitor the SR continuously. If supplemented by a full-
channel EEG once a day, this device could replace the need
for continuous full-channel recordings. Against the back-
ground of the scarcity of data on barbiturate-induced coma in
children [10], we opted to conduct a study to explore the use-
fulness of the BIS monitor during barbiturate-induced coma in
critically ill children who require intensive neuro-monitoring.
For this purpose, BIS recordings were compared with stand-
ard full-channel EEG recordings.
Materials and methods
Patients
We conducted a prospective observational pilot study at the
paediatric surgical intensive care unit (ICU) and the paediatric
ICU of our level-three children's hospital. Because of the
strictly observational and noninvasive nature of the study, the
institutional review board waived the need for approval. Annu-
ally, our paediatric surgical PSICU admits some 10 patients
with a Glasgow Coma Score of 8 or less after TBI, which is
considered an indication for intracranial pressure monitoring.
In about half of these patients, it is necessary to induce a bar-
biturate coma, after all other methods to decrease intracranial
pressure have failed [11]. In addition, every year our paediatric
ICU admits three to four patients with refractory GCSE for
treatment of their condition with barbiturate coma. All children
with TBI or GCSE in whom a barbiturate coma was induced
from November 2002 until July 2004 were eligible for inclusion
in this study. Patients with TBI facing imminent brain death
were not included.
Procedure
After admission to the ICU, the child's neurological status was
evaluated using a standard 24-channel EEG. Barbiturate
comas were induced on clinical grounds, independent of the
present study. Subsequently, EEGs as well as barbiturate
blood levels were requested and repeated on the basis of clin-
ical signs or changes in medication. There is no validated ther-
apeutic range for barbiturate plasma levels; the levels were
monitored mainly to avoid toxic concentrations. After informed
parental consent, BIS electrodes were applied as described
below during the course of the barbiturate coma. All other
interventions were recorded.
Bispectral™ index monitor
We used an A-2000 BIS™ index monitor (version 3.12;
Aspect Medical Systems), with commercially available BIS™
paediatric sensor strips with three electrodes. One electrode
is placed on the centre of the forehead, one directly above and
parallel to the eyebrow, and one in the temple area. The BIS
monitor is regularly used in anaesthesiology to quantify the
hypnotic effects of anaesthetic drugs by means of a proc-
essed cortical two-channel EEG. The monitor uses Fourier
transformation and bispectral analysis to compute a number
(BIS value) ranging from 0 (isoelectric) to 100 (fully awake). In
addition, the EEG recorded by the BIS is continuously dis-
played (BIS-EEG), together with the device's estimate of the
SR. The SR calculated by the BIS (SR-BIS) represents the
percentage of epochs during the preceding 63 seconds in
which the EEG signal is considered to be suppressed.
The algorithm within the BIS monitor sets limits for electrode
impedance and signal quality, and no BIS and SR-BIS values
are displayed if the signal has too many artifacts. The standard
settings of the device were used for artifact rejection. For
offline analysis, all BIS data were downloaded to a laptop com-
puter using the WINHIST and WINLOG program provided by
the manufacturer of the BIS monitor.
Electroencephalogram
The EEG was recorded using silver-silver chloride electrodes
attached to the skin with Elefix at electrode positions defined
by the International 10–20 system (16 channels; Fp1/2, F7/8,
T3/4, T5/6, O1/2, F3/4, C3/4 and P3/4). The EEG was
digitally recorded (sample frequency 512 Hz, -3 dB bandpass
filter settings 0.13 to 70 Hz) using a BrainlaB device (OSG,Page 2 of 7
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10 second EEG epoch, total duration of suppression of cere-
bral activity (amplitudes below 20 μV) was measured. Subse-
quently, the SR was calculated as percentage of EEG
suppression during 1 minute (SR-EEG), as closely matched to
the corresponding BIS epoch as possible (see below). Of
EEG registrations lasting more than 1 hour, the first 11 min-
utes of every full hour were captured, and the SR-EEG was
calculated from these data.
Data management
Relevant clinical data during the treatment period were
recorded. Drugs administered during the pentobarbital coma
were abstracted from an electronically guided patient data
management system.
Synchronization between the SR-BIS and SR-EEG data
proved to be a challenge. There appeared to be differences in
the algorithms used to determine SR-BIS and SR-EEG. The
algorithm of the BIS monitor seems to be less accurate in
detecting burst offset than a visual assessor, which led to an
underestimation of the SR-BIS. Synchronization was estab-
lished in several ways. First, we synchronized the computer
clocks of the BIS monitor and EEG equipment so that record-
ings could be linked. Second, in the first four included
patients, the software available at that time did not allow
recording and exportation of the raw EEG data. Therefore, in
these patients we matched patterns in SR-BIS and SR-EEG
so that their correlation in time was optimal (Figure 1). For this
purpose, we compared SR-BIS with the six SR-EEG datasets
that could be determined from the above-mentioned 10 sec-
ond epochs. That is, the first set was calculated over full min-
utes running from 0:00 to 1:00, 1:00 to 2:00 and so on until
9:00 to 10:00, yielding 10 SR-EEG values (or more if only a
single EEG file of less than 1 hour's duration was available).
The second set consisted of SR-EEG values obtained from
epochs running from 0:10 to 1:10, 1:10 to 2:10 and so on
until 9:10 to 10:10, whereas the last set was based on epochs
running from 0:50 to 1:50, 1:50 to 2:50 and so on until 9:50
to 10:50. With this approach, the maximal dysynchrony
between SR-BIS and SR-EEG is 5 seconds. In the last four
patients, the BIS monitor's raw EEG was captured using a lap-
top with WINLOG software (provided by Aspect Medical
Systems).
Statistical analysis
The data were analyzed using SPSS for Windows (version
10.0; SPSS Inc., Chicago, IL, USA). The correlation between
the SR-BIS and SR-EEG during burst suppression was tested
using the Spearman rho correlation coefficient. In case of
bimodal data, the correlation was calculated over subsets of
data [12]. These subsets of data were found in two patients
whose EEGs showed either continuous epileptic activity (SR-
EEG <40) or (some) suppression (SR-EEG ≥40), whereas no
registrations with intermediate SR-EEG values were available.
Statistical differences were considered significant if P < 0.05.
Correlations from 0.80 to 1.00 were considered large [13].
Results
Eight patients were included over a period of 18 months.
Three patients received barbiturates after TBI and five
received barbiturates to treat GCSE. Patient characteristics
are listed in Table 1. Raw BIS EEG data were collected from
patients 1, 3, 5 and 6 (the last four included patients).
Correlation between SR-BIS and SR-EEG
The paired observations of all patients are shown in Figure 2.
Correlations between SR-BIS and SR-EEG could be calcu-
Figure 1
Effect of synchronizationi i . For patient 6, correlation between Bispectral™ index suppression ratio (SR-BIS) and electroencephalographic suppression 
ratio (SR-EEG) in one EEG was poor (-0.003). After they were synchronized, moving the SR-BIS values 5 minutes back in time, the correlation 
improved to 0.92.Page 3 of 7
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ual correlations between SR-BIS and SR-EEG for these
patients were 0.67, 0.64, 0.70 and 0.70, respectively. In
patients 1 and 2 the SR distribution was bimodal, as shown by
the two 'data clouds' (Figure 3). This precluded determination
of reliable correlation values, as did the isoelectric EEG (SR-
EEG = 100 and constant) in patients 5 and 8. In the latter
patients, SR-BIS ranged from 43 to 100 (mean ± standard
deviation 95 ± 1.6).
For patients 1 and 2, correlations between SR-BIS and SR-
EEG were calculated for the relevant subsets of data (individ-
ual clouds in Figure 3). The highest correlations in these
patients were 0.5 and 0.4, respectively.
In a patient with a burst-suppression pattern with bursts of less
than 1 second duration (patient 3), SR-BIS tended to under-
estimate the suppression ratio (Figure 4).
SR-EEG and barbiturate blood levels
A total of 11 barbiturate blood levels in eight patients with cor-
responding SR-EEG values were available. The barbiturate
blood levels ranged from 18 to 33 mg/l (mean 24 mg/l) and
corresponding SR-EEG values ranged from 55 to 100. In the
two patients with an isoelectric EEG, blood levels ranged from
15 to 33 mg/l.
Discussion
The aim of this study was to evaluate the usefulness of the BIS
monitor during a barbiturate coma in paediatric ICU patients,
as proposed by Arbour [9] and Jaggi and coworkers [14]. We
found its application as a continuous monitor of the burst sup-
pression pattern to be promising. The BIS monitor is relatively
easy to use, and nurses and physicians can easily be taught
how to interpret recordings. SR-BIS and recorded EEG traces
are continuously displayed, thus enabling continuous monitor-
ing of cerebral function.
The continuously displayed real-time raw EEG traces corre-
lated well with the full-channel EEG, both at bedside and at
comparison between the EEG of the BIS and the full-channel
EEG afterward. However, correlations between SR-BIS and
SR-EEG were found to be only moderate. To some extent this
might have resulted from suboptimal synchronization, but it is
likely that some of the discrepancy is caused by differences in
the algorithms used to determine SR-BIS and SR-EEG. For
example, the algorithm employed by the BIS monitor appears
to overestimate the length of the burst and therefore underes-
timates the SR-BIS (Figure 4 [patient 3]). This underestimation
Table 1
Patient characteristics
Patient Age Sex Diagnosis Outcome Medication other than 
pentobarbital
Duration of 
barbiturate 
coma
Maximum 
barbiturate blood 
level
1 4 months Male GCSE after asphyxia P Midazolam, valproic acid 9 days 20 mg/l (day 2)
2 3 years Male GCSE due to Lennox-
Gastaut syndrome
M Lamotrigine, topiramate, valproic 
acid
3 days 37 mg/l (day 3)
3 3.5 years Female GCSE due to viral 
encephalitis
D Midazolam, carbamazepine, 
phenytoin, topiramate
14 days 70 mg/l (day 12)
4 11 years Male TBI (hit by baseball bat) D Propofol 5 days -
5 12 years Female GCSE next to mental 
retardation
D Midazolam 2 days 193 mg/l (day 7)
6 12 years Male GCSE due to viral 
encephalitis
D Valproic acid, midazolam >3 weeks 83 mg/l (day 6)
7 15 years Male TBI (hit by car) F Midazolam, morphine, propofol, 
fentanyl
16 hours 54 mg/l (day 2)
8 15 years Male TBI (hit by car) M Morphine 23 hours 47 mg/l (day 2)
D, death; F, full recovery; GCSE, generalized convulsive status epilepticus; M, minor neurological impairment; P, major neurological impairment; 
TBI, traumatic brain injury.
Figure 2
Scatter plot of SR-BIS versus SR-EEG for all eight patients. BIS, Bis-
pectral™ index; EEG, electroencephalogram; SR, suppression ratio.Page 4 of 7
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after a high-amplitude burst. That is, the computerized BIS
algorithm may be less accurate in detecting burst offset than
a visual assessor. The effects of this bias are more pro-
nounced in situations with many bursts of short duration (less
than 1 second) than in a situation with equal SR-EEG but only
a few long-duration bursts. However, visually the BIS traces
corresponded well with real-time EEG in all patients.
Additional caution should be in taken in cases in which the
EEG is (or might be expected to become) asymmetrical.
Because the BIS monitor is applied to only one side of the
head, significant changes may be overlooked or correlation
between SR-BIS and SR-EEG may be poorer than expected.
This was illustrated in a patient who had suffered a TBI,
resulting in intracranial haemorrhage on the left side of the
head (patient 4). His EEG was asymmetrical and, because SR-
Figure 3
Scatter plots SR-BIS versus SR-EEG for individual patients during burst suppression f r i i i l ti ts durin  burst suppression. BIS, Bispectral™ index; EEG, electroencephalogram; SR, sup-
pression ratio.Page 5 of 7
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SR-BIS and SR-EEG was low (0.64). In these and similar
cases, the best option appears to be simultaneous application
of two BIS monitors or to use a 'baseline' EEG to indicate
where is the optimal placement for the BIS electrodes.
Barbiturate blood levels within the normal range corresponded
with SR-EEG values ranging from 55 to 100 (that is, a brain
that is electrically silent at least half of the time). Children with
an isoelectric EEG (SR-EEG = 100) had barbiturate blood lev-
els ranging from 15 to 33 mg/l. Apart from showing these chil-
dren's individual susceptibility to barbiturates, these findings
support the assertion by Winer and coworkers [5] that blood
levels are inappropriate for titrating barbiturates.
Our study has several limitations. First, although we managed
to include most eligible patients presenting to our unit, the
group size is small because of the rare requirement for barbit-
urate-induced coma. In this respect, it should be noted that our
hospital serves as a level three paediatric ICU and regional
trauma centre (1,100 admissions a year; reference area 4 ×
106 inhabitants), implying that not many units will admit more
patients who require a barbiturate coma. This in turn suggests
that larger studies should be designed as multicentre projects.
Second, we did not monitor EEGs continuously because of
organizational limitations. This significantly reduced the
amount of available data.
Conclusion
Based on the experience gained from this pilot study, we sug-
gest that the following protocol be used in future applications.
First, a patient's brain function must be evaluated using a full-
channel EEG, combined with BIS monitoring, on an individual
basis. This combination should be employed to dose barbitu-
rates and to familiarize all those who are involved in evaluating
the relation between EEG patterns and visual display of the
BIS EEG trace in that particular patient. If the optimal dosage
has been established, and if the corresponding EEG trace and
concomitant BIS trace remain stable, then a full-channel EEG
once a day is probably sufficient to check and evaluate dosage
and settings. A new EEG must be taken if there are significant
changes in the EEG pattern of the BIS or SR-BIS values, or if
there are changes in the clinical situation or medication. Under
these conditions, the additional advantages of continuous full-
channel EEG probably do not outweigh the practical barriers
to this modality. Of course, for objective evaluation of the
safety and efficacy of barbiturate induced comas in children,
larger prospective studies are required, combining pharma-
cokinetic and pharmacodynamic studies with continuous EEG
and BIS monitoring.
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Figure 4
Burst suppression pattern with short-duration bursts in patient 3. The Bispectral™ index suppression ratio (SR-BIS) algorithm yields a value that rep-
resents an underestimate of the true electroencephalographic (EEG) suppression.
Key messages
• The BIS monitor provides continuous data on EEG sup-
pression and potentially assists in the monitoring of bar-
biturate-induced coma in children.
• An EEG must be applied if there are significant changes 
in EEG pattern, BIS, or SR-BIS values, or if there are 
changes in clinical situation or medication.
• Larger prospective studies are required that combine 
pharmacokinetics and pharmacodynamics with continu-
ous EEG and BIS monitoring to determine the safety 
and efficacy of barbiturate-induced comas in children.Page 6 of 7
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